Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhibo Dihuang Pills
- Development stage
- Unknown
- Lead developer
- Lanzhou Foci
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zhibo Dihuang Pills (知柏地黄丸) is a traditional Chinese medicine (TCM) formulation developed and manufactured by Lanzhou Foci Pharmaceutical. It is an extension of the classic Liuwei Dihuang formulation, enhanced with the addition of Anemarrhena (Zhimu) and Phellodendron bark (Huangbai). This oral medication is primarily used to "nourish yin and reduce fire" (滋阴降火). It is indicated for symptoms associated with yin deficiency and internal heat, such as tidal fever, night sweats, dry mouth, sore throat, tinnitus, and seminal emission. The formulation works through the synergistic effects of its eight herbal components: Rehmannia root, Cornus fruit, Chinese yam, Poria, Alisma, Moutan bark, Anemarrhena, and Phellodendron bark. Modern research suggests the formulation may possess immunomodulatory and endocrine-regulating properties.
- Brand names
- Zhibo Dihuang Wan
- Other names
- 知柏地黄丸Zhibo Dihuang Pills
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)SRC (Proto-oncogene tyrosine-protein kinase Src)VEGFA (Vascular endothelial growth factor A)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on Zhibo Dihuang Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhibo Dihuang Pills.